 HC Wainwright points out that investors are enthusiastic about SpringWorks Therapeutics Inc NASDAQ: SWTX nirogacestat clinical profile for desmoid tumors after the RD day held last week. As per a survey of U.S. oncologists treating patients with desmoid tumors, roughly 80. 